Predictors of poor function in RA based on two prospective UK inception cohorts. Do comorbidities matter?

被引:14
作者
Busby, Amanda D. [1 ]
Wason, James [2 ]
Pratt, Arthur G. [3 ,4 ]
Young, Adam [1 ]
Isaacs, John D. [3 ,4 ]
Nikiphorou, Elena [5 ,6 ]
机构
[1] Univ Hertfordshire, Ctr Hlth Serv & Clin Res, Life & Med Sci, Coll Lane, Hatfield AL10 9AB, Herts, England
[2] Newcastle Univ, Populat Hlth Sci Inst, Newcastle Upon Tyne, Tyne & Wear, England
[3] Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England
[4] Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Hosp, Musculoskeletal Unit, Newcastle Upon Tyne, Tyne & Wear, England
[5] Kings Coll London, Ctr Rheumat Dis, London, England
[6] Kings Coll Hosp London, Rheumatol Dept, London, England
基金
英国医学研究理事会;
关键词
sociodemographic factors; comorbidity; multimorbidity; Health Assessment Questionnaire; rheumatoid arthritis; DISABILITY INDEX HAQ; RHEUMATOID-ARTHRITIS; SCORE; IMPACT; LINE;
D O I
10.1093/rheumatology/keab598
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Evidence suggests that factors beyond disease activity associate with functional disability in RA. The primary study objective was to explore associations between comorbidities, sociodemographic factors and functional outcomes at five and 10 years. Methods RA patients from two UK prospective cohorts were grouped into low (<1.5) and high (>= 1.5) five- and 10-year health assessment questionnaire (HAQ) score. Clinical variables (e.g. disease activity, rheumatoid nodules, erosions) and sociodemographic factors (e.g. ethnicity, deprivation) were recorded at baseline and yearly thereafter. Comorbidity was measured using the Rheumatic Diseases Comorbidity Index (RDCI). Binary logistic regression models were fitted using multiple imputation. Results In total, 2701 RA patients were recruited (mean age 56.1 years, 66.9% female). A total of 1718 (63.4%) had five-year and 820 (30.4%) 10-year follow-up data. In multivariable analysis, no association was found between RDCI and HAQ >= 1.5 at five or 10 years. Sociodemographic factors (increased age at disease onset, female gender, minority ethnicity) were associated with higher odds of HAQ >= 1.5 at five and 10 years, with worse deprivation additionally associated with HAQ >= 1.5 at 10 years (OR 0.79, 95% CI: 0.69, 0.90). Conclusion Comorbidities at baseline have not been found to be associated with worse RA functional outcome in the long-term. On the other hand, sociodemographic factors, independently of disease measures, are associated with worse functional outcome in RA at five and 10 years, in models adjusting for comorbidity burden. Tailoring management interventions according to not only clinical disease parameters but also patient sociodemographic factors may improve long-term outcomes including functional disability.
引用
收藏
页码:1563 / 1569
页数:7
相关论文
共 21 条
[1]   Tapering of Etanercept is feasible in patients with Rheumatoid Arthritis in sustained remission: a pragmatic randomized controlled trial [J].
Bertrand, D. ;
Stouten, V ;
De Cock, D. ;
Pazmino, S. ;
Doumen, M. ;
de Wergifosse, I ;
Joly, J. ;
Badot, V ;
Corluy, L. ;
Hoffman, I ;
Taelman, V ;
De Knop, K. ;
Geens, E. ;
Langenaken, C. ;
Lenaerts, J. L. ;
Lenaerts, J. ;
Walschot, M. ;
Mannaerts, J. ;
Westhovens, R. ;
Verschueren, P. .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2022, 51 (06) :470-480
[2]   Validation of methods for converting the original Disease Activity Score (DAS) to the DAS28 [J].
Carpenter, Lewis ;
Norton, Sam ;
Nikiphorou, Elena ;
Kiely, Patrick ;
Walsh, David A. ;
Dixey, Josh ;
Young, Adam .
RHEUMATOLOGY INTERNATIONAL, 2018, 38 (12) :2297-2305
[3]   Persistently moderate DAS-28 is not benign: loss of function occurs in early RA despite step-up DMARD therapy [J].
Conaghan, Philip G. ;
Hensor, Elizabeth M. A. ;
Keenan, Anne-Maree ;
Morgan, Ann W. ;
Emery, Paul .
RHEUMATOLOGY, 2010, 49 (10) :1894-1899
[4]   Burden and trajectory of multimorbidity in rheumatoid arthritis: a matched cohort study from 2006 to 2015 [J].
England, Bryant R. ;
Roul, Punyasha ;
Yang, Yangyuna ;
Sayles, Harlan ;
Yu, Fang ;
Michaud, Kaleb ;
Xie, Fenglong ;
Curtis, Jeffrey R. ;
Mikuls, Ted R. .
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (03) :286-292
[5]   Validation of the Rheumatic Disease Comorbidity Index [J].
England, Bryant R. ;
Sayles, Harlan ;
Mikuls, Ted R. ;
Johnson, Dannette S. ;
Michaud, Kaleb .
ARTHRITIS CARE & RESEARCH, 2015, 67 (06) :865-872
[6]  
Fanouriakis A, 2018, CLIN EXP RHEUMATOL, V36, P806
[7]  
HAWLEY DJ, 1991, J RHEUMATOL, V18, P1552
[8]   Measures of Functional Status and Quality of Life in Rheumatoid Arthritis Health Assessment Questionnaire Disability Index (HAQ), Modified Health Assessment Questionnaire (MHAQ), Multidimensional Health Assessment Questionnaire (MDHAQ), Health Assessment Questionnaire II (HAQ-II), Improved Health Assessment Questionnaire (Improved HAQ), and Rheumatoid Arthritis Quality of Life (RAQoL) [J].
Maska, Leann ;
Anderson, Jaclyn ;
Michaud, Kaleb .
ARTHRITIS CARE & RESEARCH, 2011, 63 :S4-S13
[9]  
Ministry of Housing Communities and Local Government, 2015, IND MULT DEPR SCOR 2
[10]   Health assessment questionnaire-disability index (HAQ-DI) score at the start of biological disease-modifying antirheumatic drug (bDMARD) therapy is associated with radiographic progression of large joint damage in patients with rheumatoid arthritis [J].
Nakajima, Arata ;
Aoki, Yasuchika ;
Terayama, Keiichiro ;
Sonobe, Masato ;
Takahashi, Hiroshi ;
Saito, Masahiko ;
Nakagawa, Koichi .
MODERN RHEUMATOLOGY, 2017, 27 (06) :967-972